Drug Type Small molecule drug |
Synonyms IM-502 |
Target |
Action inhibitors |
Mechanism PI3Kγ inhibitors(Phosphatidylinositol-4,5-Bisphosphate 3 kinase gamma inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | China | 22 May 2026 |





